News and Insights

Search all news & insights

    Latest news

    Show
    news from

    Autolus Therapeutics Presents Positive Results from Pivotal Phase 2 FELIX study in adult r/r B-ALL at ASCO

    Freeline to Present at 2023 Jefferies Healthcare Conference

    Freeline Reports First Quarter 2023 Financial Results and Business Highlights

    Autolus Therapeutics to hold Analyst call to highlight data at ASCO from the Pivotal Phase 2 FELIX study of obe-cel data in adult r/r B-ALL

    Freeline Granted ILAP Designation in United Kingdom by MHRA for FLT201, an Investigational Gene Therapy for the Treatment of Gaucher Disease

    SwanBio Unveils Research in Next Generation CNS Capsids at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

    View all news

    Latest insights & articles

    Show
    insights & articles from

    Leveraging the Syncona team for our next phase of growth

    Good science must survive in challenging markets

    Scaling for growth

    Building a global leader in retinal gene therapy

    Welcoming our first Windsor Fellowship intern to Syncona

    Ed Hodgkin and Magdalena Jonikas discuss OMass Series B

    View all insights & articles

    Latest publications & presentations

    Show presentations from

    Autolus Corporate Presentation - March 2023

    Download PDF (1.58Mb)

    Achilles Corporate Presentation - March 2023

    Download PDF (3.71Mb)

    Achilles Corporate Presentation - January 2023

    Download PDF (3.11Mb)

    Autolus Corporate Presentation - January 2023

    Download PDF (1.57Mb)

    Freeline Corporate Presentation - January 2023

    Download PDF (1.59Mb)

    Autolus Corporate Presentation - August 2022

    Download PDF (1.79Mb)
    View all publications & presentations

    Search